Cell line · CVCL_2478
HCT 8
Cancer cell line, Homo sapiens. Colon adenocarcinoma. 43 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. HCT 8. Cell lines, record CVCL_2478. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_2478
On this page
Cell line
As Cellosaurus gives it.
- Name
- HCT 8
- Accession
- CVCL_2478
- RRID
- RRID:CVCL_2478
- Synonyms
- HCT-8, HCT8
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 67Y
- Category
- Cancer cell line
- Diseases
- Colon adenocarcinoma (NCIt C4349)
- Derived from
- Colon (in situ)
- Cell type
- Epithelial cell of colon
- Parent
- __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18 (CVCL_3449)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers43
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cholesterol Reprograms Oxysterol Metabolism via the LOX1/CH25H/CYP7B1 Signaling Axis to Drive Multidrug Resistance in Colorectal Cancer. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model. | Front Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DDR1 Promotes Immune Evasion in Colorectal Cancer by Orchestrating IL33-Mediated M2-like Polarization of Tumor-Associated Macrophages. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Colorectal cancer-derived osteopontin rewires macrophages into a pro-metastatic M2 state via the PI3K/AKT/CSF1-CSF1R axis. | Cell Death Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Thimerosal Inhibits Tumor Malignant Progression through Direct Action and Enhancing the Efficacy of PD-1-Based Immunotherapy. | Oncol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cathepsin-D-mediated MHC class I degradation contributes to immune evasion in colorectal cancer. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Colorectal cancer cell-derived exosomes induce metabolic reprogramming of cancer-associated fibroblasts to promote colorectal cancer growth. | Discov Oncol | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 43
See all 43 papersRelatives10
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18 | CVCL_3449 | Cell lines | |
| Derived from it | HCT-8-Luc2-tdT | CVCL_A9CQ | Cell lines | |
| Derived from it | HCT-8-mCherry | CVCL_A9CR | Cell lines | |
| Derived from it | HCT-8-tdT | CVCL_A9CS | Cell lines | |
| Derived from it | HCT-8/E11 | CVCL_5679 | Cell lines | |
| Derived from it | HCT-8/R1 | CVCL_5945 | Cell lines | |
| Derived from it | HCT-8/S10 | CVCL_5947 | Cell lines | |
| Derived from it | HCT-8/S11 | CVCL_5682 | Cell lines | |
| Derived from it | HCT-8/VCR | CVCL_A9CF | Cell lines | |
| Derived from it | HCT-8R | CVCL_S851 | Cell lines |
Cell banks9
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| AddexBio | C0009017/4907 | Cellosaurus | |
| BCRC | 60303 | BCRC | |
| CCTCC | GDC0201 | Cellosaurus | |
| CLS | 300210 | CLS | |
| ECACC | 90032006 | ECACC | |
| ICLC | HTL99005 | ICLC | |
| IZSLER | BS TCL 97 | Cellosaurus | |
| KCB | KCB 2011103YJ | Cellosaurus | |
| KCLB | 10244 | KCLB |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_2478
GET https://conductscience.org/api/cell-lines/v1/CVCL_2478/papers?page=2